Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
SRI provides broad expertise in antiviral and vaccine efficacy /safety studies, utilizing its extensive collection of human and animal Influenza isolates, and providing: in vitro evaluation, customizable in vivo models, vaccine discovery /development, discovery tools in ferret model. SRI offers research, discovery /development CRO services, Phase I Clinical Trials.
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.